Global Indemnity Group (NASDAQ:GBLI) reported second-quarter net income of $11.1 million, up 8% from $10.3 million a year earlier, as the insurer cited continued strength in loss performance, higher investment income and growth in several core businesses.
For the first six months of 2026, net incom
Global Indemnity's Q3 2025 earnings beat profit forecasts with $1.08 EPS, though revenue missed. The stock rose on strong underwriting income and strategic growth initiatives.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
